InvestorsHub Logo
Followers 62
Posts 7579
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Tuesday, 04/11/2023 8:09:34 AM

Tuesday, April 11, 2023 8:09:34 AM

Post# of 427043
From SA :QUOTE..."The deal(in which Pfizer bought Seagen for $43 billion) will hurt near term earnings; in fact, a neutral impact to adjusted earnings per share is only seen three or four years post closing, and that is after the anticipation of a billion in costs synergies at such a point in time!"

A $4 billion investment in Amarin by Pfizer would have a POSITIVE impact to earnings in LESS than 3 or 4 years....especially with a statin-EPA combo in Europe...and possibly one in the U.S.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News